Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000019617-25-000183·JPMORGAN CHASE & CO
Schedule 13G ownership disclosure
Tenaya Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 87990A106
Event date: 2024-12-31
- Filing-level shares
- 5,154,950.0
- Percent of class
- 6.5%
- JPMORGAN CHASE & CO.
Shares: 5,154,950.0 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-000183
- Form type
- SCHEDULE 13G
- Filer
- JPMORGAN CHASE & CO
- CIK
- CIK 19617
- Filed
- Feb 10, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership